Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is U  [Clear All Filters]
2024
Mori H, Goji A, Hara M. Upregulation of Intracellular Zinc Ion Level after Differentiation of the Neural Stem/Progenitor Cells In Vitro with the Changes in Gene Expression of Zinc Transporters. Biol Trace Elem Res. 2024.
Lozinski M, Lumbers ER, Bowden NA, Martin JH, Fay MF, Pringle KG, Tooney PA. Upregulation of the Renin-Angiotensin System Is Associated with Patient Survival and the Tumour Microenvironment in Glioblastoma. Cells. 2024;13(7).
Maruhashi T, Kajikawa M, Kishimoto S, Yamaji T, Harada T, Hashimoto Y, Mizobuchi A, Tanigawa S, Yusoff FMohamad, Nakano Y, et al. Upstroke time is a more useful marker of atherosclerosis than percentage of mean arterial pressure for detecting coronary artery disease in subjects with a normal ankle-brachial index. Hypertens Res. 2024.
Fiorentino F, Fabbrizi E, Raucci A, Noce B, Fioravanti R, Valente S, Paolini C, De Maria R, Steinkuhler C, Gallinari P, et al. Uracil- and Pyridine-Containing HDAC Inhibitors Displayed Cytotoxicity in Colorectal and Glioblastoma Cancer Stem Cells. ChemMedChem. 2024:e202300655.
Hou Y, Chu X, Park J-H, Zhu Q, Hussain M, Li Z, Madsen HBorland, Yang B, Wei Y, Wang Y, et al. Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions. Alzheimers Dement. 2024.
Gao H, Wang J, Zheng X, Pei X, Zheng Y, Zhai W, Zhang R, Chen X, Ma Q, Wei J, et al. Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort. Front Cell Infect Microbiol. 2024;14:1324019.
Yang Y, He Z, Wu S. Ursolic acid alleviates paclitaxel-induced peripheral neuropathy through PPARγ activation. Toxicol Appl Pharmacol. 2024:116883.
Turner L, Wang JChieng, Martinez JRamon, Najjar S, Arachchilage TRajapaksha, Sahrai V. US businesses engaged in direct-to-consumer marketing of perinatal stem cell interventions following the Food and Drug Administration's enforcement discretion era. Cytotherapy. 2024.
Matthews KRW, Lowe SJ, Master Z. US state laws on medical freedom and investigational stem cell procedures: a call to focus on state-based legislation. Cytotherapy. 2024.
Kremer V, Rheinheimer A, Rodrigues ALuiza, Taborda A, Coelho R, Zanette A. The Use of a High Flow PICC Catheter for Stem Cell and Lymphocyte Apheresis: The Initial Experience of a Pediatric Oncology Center in Brazil. J Pediatr Surg. 2024.
Herreros MDolores, Ramirez J-M, Otero-Piñeiro AM, Martí-Gallostra M, Badiola I, Enríquez-Navascues JM, Millan M, Barreiro E, de Juan Fde la Port, Alecha JSuárez, et al. Use of Darvadstrocel (Allogenic Stem Cell Therapy) for Crohn's Fistulas in Real Clinical Practice: The National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME Study). Dis Colon Rectum. 2024.
Brzozowska W, Wojtczak I, Sprynskyy M. The Use of Diatoms in the Synthesis of New 3D Micro-Nanostructured Composites (SiO/CaCO/C/NdVONPs and SiO/CaO/C/NdVONPs) Exhibiting an Intense Anti-Stokes Photoluminescence. Materials (Basel). 2024;17(2).
Benítez-Carabante MI, Bueno D, L García A, I Torija L, Marsal J, Oficialdegui MLUria, Panesso M, Molina B, C Bieler B, Palomo P, et al. Use of eculizumab in pediatric patients with high-risk transplant-associated thrombotic microangiopathy: outcomes and risk factors associated with response and survival. A retrospective study on behalf of the Spanish Group for Hematopoietic Transplantatio. Transplant Cell Ther. 2024.
Shahzad M, Khalid MFareed, Amin MKashif, Ammad-Ud-Din M, Ilyas U, Mushtaq AH, Butt A, Anwar I, Chaudhary SGull, Ahmed N, et al. Use of Endpoints in Phase III Randomized Controlled Trials for Hematopoietic Stem Cell Transplantation Over the Last 15 Years: A Systematic Review. Hematol Oncol Stem Cell Ther. 2024;17(2):88-94.
Graham C, Litzow M. The use of haploidentical stem cell transplant as an alternative donor source in patients with decreased access to matched unrelated donors. Hematology. 2024;29(1):2338300.
Gandikota C, Vaddadi K, Sivasami P, Huang C, Liang Y, Pushparaj S, Deng X, Channappanava R, Metcalf JP, Liu L. The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses. J Med Virol. 2024;96(4):e29579.
Tragoonlugkana P, Chitchongyingcharoen N, Pruksapong C, Hassan S, Ngamkham K, Kamprom W, Supokawej A. The Use of Human Platelet Lysate as a Coating Substance for Adipose-Derived Stem Cell Expansion. Front Biosci (Landmark Ed). 2024;29(2):88.
Bai X. Use of induced pluripotent stem cell-derived brain cells, organoids, assembloids, and blood-brain barrier models in understanding alcohol and anesthetic-induced brain injuries: an emerging perspective. Neural Regen Res. 2024;19(5):953-954.
Kwartler CS, Pinelo JEmiliano E. Use of iPSC-Derived Smooth Muscle Cells to Model Physiology and Pathology. Arterioscler Thromb Vasc Biol. 2024.
Traore K, Zirkin B. Use of methodology to investigate phthalate effects on the differentiation of seminiferous tubule-associated stem cells to form Leydig cells and on the Leydig cells derived from the stem cells. Front Toxicol. 2024;6:1352294.
de Souza EBaia, Marin DDubeibe, Ramos ASarges, Homobono BPorpino, Ramos Pdo Carmo d, de Brito VCunha, da Cruz GSantos, da Costa NNogueira, Cordeiro Mda Silva, Santos Sdo Socorro. Use of platelet-rich plasma on in vitro maturation during bovine embryo production. Anim Reprod. 2024;21(1):e20230107.
Blaszkiewicz J, Duncan SA. Use of stem cell-derived hepatocytes to model liver disease. J Hepatol. 2024.
Pokorska J, Sawicki S, Gabryś J, Kułaj D, Bauer EAgnieszka, Lenart-Boroń A, Bulanda K, Kuchta-Gładysz M, Grzesiakowska A, Kemilew J, et al. The use of stem cells in the treatment of mastitis in dairy cows. Sci Rep. 2024;14(1):10349.
McCloskey MC, Kasap P, Trempel M, Widom LP, Kuebel J, Chen K, Gaborski TR, Engelhardt B, McGrath JL. Use of the MicroSiM (µSiM) Barrier Tissue Platform for Modeling the Blood-Brain Barrier. J Vis Exp. 2024;(203).
Sun Y, Wang X, Chen W-M, Hao Y, Di Li L-, Li J-Y, Sun K, Shi Z-Y, Jiang H, Jiang Q, et al. Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia. Hematol Oncol. 2024;42(2):e3264.

Pages